semaglutide and myasthenia gravis specific immunotherapy: monoclonal antibodies - Cai - 2019 - Annals of the New York Academy of Sciences Updated 2025 guidelines for myasthenia

Its the first oral GLP-1 for weight loss

From dose titration and hormonal adaptation to dietary habits and psychological triggers, several factors can explain persistent hunger

The key is working with your provider to find the dose that balances results with tolerability, and knowing exactly how many units that dose translates to for your specific concentration

Yes, like every other weight loss medication, GLP-1 medications also have temporary side effects

Each offers unique benefits so knowing the difference is important before making a decision

Roles of eicosanoids in regulating inflammation and neutrophil migration as an innate host response to bacterial infections